Skip to main content

previous disabled Page of 2
and
  1. No Access

    Article

    Extra-axial chordoma: a clinicopathologic analysis of six cases

    Extra-axial chordoma is an exceedingly rare tumor, with only 28 cases reported in the literature to date. Axial and extra-axial chordoma exhibits complete morphologic and immunophenotypic (expression of brachy...

    A. Righi, M. Sbaraglia, M. Gambarotti, S. Cocchi, G. Drago, R. Casadei in Virchows Archiv (2018)

  2. No Access

    Article

    CD99 regulates neural differentiation of Ewing sarcoma cells through miR-34a-Notch-mediated control of NF-κB signaling

    Sarcomas are mesenchymal tumors characterized by blocked differentiation process. In Ewing sarcoma (EWS) both CD99 and EWS-FLI1 concur to oncogenesis and inhibition of differentiation. Here, we demonstrate tha...

    S Ventura, D N T Aryee, F Felicetti, A De Feo, C Mancarella, M C Manara in Oncogene (2016)

  3. Article

    Open Access

    Gemcitabine and docetaxel in relapsed and unresectable high-grade osteosarcoma and spindle cell sarcoma of bone

    Few new compounds are available for relapsed osteosarcoma. We retrospectively evaluated the activity of gemcitabine (G) plus docetaxel (D) in patients with relapsed high-grade osteosarcoma and high-grade spind...

    E. Palmerini, R. L. Jones, E. Marchesi, A. Paioli, M. Cesari, A. Longhi in BMC Cancer (2016)

  4. No Access

    Article

    Sclerosing epithelioid fibrosarcoma of the thigh: report of two cases with synchronous bone metastases

    We report two cases of sclerosing epithelioid fibrosarcoma occurring in the deep soft tissue of the thigh, confirmed by molecular analysis and associated with bone metastases in the lumbar vertebrae and the il...

    A. Righi, M. Gambarotti, M. Manfrini, S. Benini, G. Gamberi, S. Cocchi in Virchows Archiv (2015)

  5. Article

    Open Access

    Integrated approaches to miRNAs target definition: time-series analysis in an osteosarcoma differentiative model

    microRNAs (miRs) are small non-coding RNAs involved in the fine regulation of several cellular processes by inhibiting their target genes at post-transcriptional level. Osteosarcoma (OS) is a tumor thought to ...

    A. Grilli, M. Sciandra, M. Terracciano, P. Picci, K. Scotlandi in BMC Medical Genomics (2015)

  6. No Access

    Article

    Gene expression profiling of giant cell tumor of bone reveals downregulation of extracellular matrix components decorin and lumican associated with lung metastasis

    Giant cell tumor of bone (GCTB) displays worrisome clinical features such as local recurrence and occasionally metastatic disease which are unpredictable by morphology. Additional routinely usable biomarkers d...

    M. Lieveld, E. Bodson, G. De Boeck, B. Nouman, A. M. Cleton-Jansen in Virchows Archiv (2014)

  7. No Access

    Article

    CD99 suppresses osteosarcoma cell migration through inhibition of ROCK2 activity

    CD99, a transmembrane protein encoded by MIC2 gene is involved in multiple cellular events including cell adhesion and migration, apoptosis, cell differentiation and regulation of protein trafficking either in ph...

    C Zucchini, M C Manara, R S Pinca, P De Sanctis, C Guerzoni, M Sciandra in Oncogene (2014)

  8. Article

    Open Access

    Preclinical validation of Aurora kinases-targeting drugs in osteosarcoma

    Aurora kinases are key regulators of cell cycle and represent new promising therapeutic targets in several human tumours.

    E Tavanti, V Sero, S Vella, M Fanelli, F Michelacci in British Journal of Cancer (2013)

  9. No Access

    Article

    1q gain and CDT2 overexpression underlie an aggressive and highly proliferative form of Ewing sarcoma

    Despite extensive characterization of the role of the EWS-ETS fusions, little is known about secondary genetic alterations and their clinical contribution to Ewing sarcoma (ES). It has been demonstrated that t...

    C Mackintosh, J L Ordóñez, D J García-Domínguez, V Sevillano, A Llombart-Bosch in Oncogene (2012)

  10. No Access

    Article

    Efficacy of and resistance to anti-IGF-1R therapies in Ewing's sarcoma is dependent on insulin receptor signaling

    Identification of patient selection criteria and understanding of the potential mechanisms involved in the development of resistance are crucial for an appropriate and successful design of clinical trials with...

    C Garofalo, M C Manara, G Nicoletti, M T Marino, P-L Lollini, A Astolfi in Oncogene (2011)

  11. No Access

    Article

    Morphological and immunophenotypic features of primary and metastatic giant cell tumour of bone

    Giant cell tumour of bone (GCTB) is a primary tumour of bone that may rarely, in the absence of malignant cytological features, produce metastatic lesions, most commonly in the lungs. Whether these lung nodule...

    M. Alberghini, K. Kliskey, T. Krenacs, P. Picci, L. Kindblom, R. Forsyth in Virchows Archiv (2010)

  12. No Access

    Article

    Parosteal osteosarcoma dedifferentiating into telangiectatic osteosarcoma: importance of lytic changes and fluid cavities at imaging

    This study was performed to assess the imaging findings in cases of parosteal osteosarcoma dedifferentiated into telangiectatic osteosarcoma. Parosteal osteosarcoma is a low-grade well-differentiated malignant...

    M. Azura, D. Vanel, M. Alberghini, P. Picci, E. Staals, M. Mercuri in Skeletal Radiology (2009)

  13. No Access

    Article

    CD99 isoforms dictate opposite functions in tumour malignancy and metastases by activating or repressing c-Src kinase activity

    CD99 gene encodes two distinct proteins, produced by alternative splicing of CD99 gene transcript. Full-length CD99 isoform (CD99wt) is formed by an extracellular domain, followed by a transmembrane domain and a ...

    K Scotlandi, M Zuntini, M C Manara, M Sciandra, A Rocchi, S Benini, G Nicoletti in Oncogene (2007)

  14. No Access

    Article

    Histologically verified lung metastases in benign giant cell tumours—14 cases from a single institution

    From 1975 to 1997, 649 cases of benign giant cell tumours of the bone were treated at the Istituto Rizzoli. Fourteen patients (2.1%) experienced lung metastases after a mean of 35.2 months. The time interval b...

    M. Dominkus, P. Ruggieri, F. Bertoni, A. Briccoli, P. Picci in International Orthopaedics (2006)

  15. No Access

    Chapter

    Prognostic and Therapeutic Targets in the Ewing's Family of Tumors (PROTHETS)

    P. Picci, K. Scotlandi, M. Serra, A. Rizzi in New trends in cancer for the 21st century (2006)

  16. No Access

    Chapter

    Autologous Peripheral Blood Stem Cell Transplantation in Childhood Metastatic Osteosarcoma

    Over the past few years the outcome of patients with high grade osteosarcoma (OST) improved dramatically, with survival rates rising from 15% up to 70% [1]. The relatively large series of subjects reported by ...

    R. Miniero, A. Busca, A. Brach del Prever in Transplantation in Hematology and Oncology (2000)

  17. No Access

    Chapter

    Autologous Peripheral Blood Stem Cell Transplantation in Childhood Metastatic Osteosarcoma

    Over the past few years the outcome of patients with high grade osteosarcoma (OST) has improved dramatically with survival rates rising from 15% up to 70% [1]. The relatively large series of subjects reported ...

    R. Miniero, A. Busca, A. Brach de Prever in Transplantation in Hematology and Oncology (2000)

  18. No Access

    Article

    Alveolar soft part sarcoma

     We present a rare case of alveolar soft-tissue sarcoma, with extensive bone invasion. The differential diagnosis with bone metastasis and primary bone tumors is dicscussed.

    P. Aluigi, L. Sangiorgi, P. Picci in Skeletal Radiology (1996)

  19. No Access

    Chapter

    Surgery of Osteosarcoma of the extremities: Indications and complications in the recent Experience at the Istituto Ortopedico Rizzoli

    In the surgical treatment of localized osteosarcoma of the extremities, limb-salvage procedures are currently used whenever wide surgical margins can be achieved [13]. The increased indications for conservative ...

    P. Ruggieri, R. Biagini, G. Bacci in Osteosarcoma in Adolescents and Young Adul… (1993)

  20. No Access

    Chapter

    Neoadjuvant chemotherapy for nonmetastatic osteosarcoma of the extremities: The recent experience at the Rizzoli Institute

    In the late 1970s Rosen et al. was the first to report the advantages of primary chemotherapy and delayed surgery (neoadjuvant chemotherapy) over adjuvant chemotherapy. The excellent results reported by these ...

    G. Bacci, P. Picci, S. Ferrari, M. Avella in Osteosarcoma in Adolescents and Young Adul… (1993)

previous disabled Page of 2